Lakefront Biotherapeutics (LKFT) Capital Expenditures (QoQ) (2016 - 2026)
Lakefront Biotherapeutics (LKFT) Capital Expenditures (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.48% |
| Dec 31, 2025 | 1,005.40% |
| Sep 30, 2025 | 31.41% |
| Jun 30, 2025 | 18.45% |
| Mar 31, 2025 | -118.18% |
| Dec 31, 2024 | 761.16% |
| Sep 30, 2024 | -27.65% |
| Jun 30, 2024 | 11.28% |
| Mar 31, 2024 | -112.57% |
| Mar 31, 2023 | -109.03% |
| Jun 30, 2020 | -121.25% |
| Mar 31, 2020 | -107.22% |
| Dec 31, 2019 | 423.11% |
| Sep 30, 2019 | -319.42% |
| Jun 30, 2019 | -39.32% |
| Mar 31, 2019 | -114.35% |
| Dec 31, 2018 | 1,019.76% |
| Sep 30, 2018 | 30.65% |
| Jun 30, 2018 | -51.93% |
| Mar 31, 2018 | -30.13% |